Today: 20 May 2026
Netflix stock ticks up as Delaware judge blocks Paramount fast-track in Warner deal fight
15 January 2026
2 mins read

Netflix stock ticks up as Delaware judge blocks Paramount fast-track in Warner deal fight

New York, Jan 15, 2026, 12:16 EST — Regular session

  • Netflix shares edged up as a Delaware judge refused to fast-track Paramount Skydance’s lawsuit connected to Warner Bros Discovery’s deal process
  • The idea of an all-cash Netflix bid for Warner’s studios and streaming assets has resurfaced.
  • Investors are eyeing Netflix’s Jan. 20 earnings report for insights and any updates on deals

Shares of Netflix (NFLX.O) ticked up 0.6% to $89.08 midday Thursday, as investors digested a Delaware court decision related to its planned buyout of Warner Bros Discovery’s studios and streaming units.

The ruling keeps the takeover battle alive, leaving timing and price uncertain. Traders are watching the stock closely, viewing it as a gauge of whether Netflix can pull off a game-changing deal without stumbling over politics, financing, or regulatory hurdles.

Next Tuesday brings Netflix’s quarterly results, adding pressure to an already busy week. The Warner process looms large, casting uncertainty over what might have been a straightforward earnings report.

Reuters reported this week that Netflix plans to shift its bid to an all-cash offer for Warner’s studios and streaming units, moving away from an earlier $82.7 billion cash-and-stock deal. Paramount Skydance (PSKY.O) is also in the race, pushing a $30-per-share all-cash bid for the entire company. Lawmakers have raised alarms about increased media consolidation, warning it could limit consumer choice and drive up prices. Netflix has agreed to pay a $5.8 billion termination fee if regulators block the deal, while Warner would owe $2.8 billion should it walk away.

On Thursday, Delaware Chancery Court Vice Chancellor Morgan Zurn denied Paramount Skydance’s bid to fast-track its lawsuit demanding more details about Warner’s decision to support Netflix’s offer. Paramount said it would continue pushing for disclosures, while Warner dismissed the lawsuit as a distraction. Its lawyer told the court, “This movie is still being shot.” Paramount’s tender offer—aimed at buying shares directly from shareholders—is set to expire on Jan. 21. No vote on the Netflix deal has been scheduled yet, according to the report. Reuters

Shares of Warner Bros Discovery slipped 0.2%, while Paramount Skydance dipped 0.7% in midday trading.

Analysts are revising forecasts ahead of earnings. TD Cowen’s John Blackledge downgraded his price target to $115 from $142 but maintained a Buy rating. He cited the firm’s ad-buyer research, which signals “incremental advertiser adoption,” and noted consumer survey data that kept Netflix leading in living-room viewing this quarter. TipRanks

The downside is clear. An all-cash deal might spark concerns over balance-sheet pressure. Plus, a lengthy regulatory review could drag out the Warner bid, weighing on the stock despite Netflix’s core business staying strong.

Netflix will release its fourth-quarter results and business outlook on Jan. 20 around 1:01 p.m. Pacific time, with a management video interview set for 1:45 p.m. Pacific time.

Next week’s numbers will draw investor attention to any update on the Warner bid, the outlook on advertising and margins, and how much room Netflix claims it has left for strategic spending.

Stock Market Today

  • Trump's Truth Social Withdraws Bitcoin and Bitcoin-Ethereum ETF Applications Amid Market Pressure
    May 20, 2026, 7:22 AM EDT. Trump Media & Technology Group has withdrawn its applications for Bitcoin and Bitcoin-Ethereum exchange-traded funds (ETFs), citing a strategic shift to pursue a different regulatory framework under the Investment Company Act of 1940 ('40 Act) instead of the Securities Act of 1933 ('33 Act). Yorkville America, the investment advisor, highlighted that the '40 Act allows more flexible investment strategies. This move comes amid intense fee competition in the U.S. spot Bitcoin ETF market, valued at $57.4 billion since January 2024, following Morgan Stanley's MSBT launch, which offers a low 0.14% expense ratio. The withdrawal underscores heightened competition and evolving regulatory approaches in the crypto ETF space.

Latest articles

InMed Pharmaceuticals (INM) Stock Doubled on Mentari Merger — Why the Rally Is Already Being Tested

InMed Pharmaceuticals (INM) Stock Doubled on Mentari Merger — Why the Rally Is Already Being Tested

20 May 2026
InMed Pharmaceuticals shares fell 14.4% to $1.37 in early pre-market trading Wednesday, after surging 135% Tuesday on news of an all-stock merger with Mentari Therapeutics and a planned $290 million private placement. Pre-merger InMed shareholders are expected to own about 1.51% of the combined company, which will operate as Mentari Therapeutics and focus on migraine drug development.
Micware Shares Swing Pre-Market After 26% Drop on Nasdaq Debut

Micware Shares Swing Pre-Market After 26% Drop on Nasdaq Debut

20 May 2026
Micware shares jumped 97.7% to $9.33 in premarket U.S. trading Wednesday, rebounding above last week’s $8 IPO price after closing Tuesday at $4.72. A new SEC filing showed Toyota owns 11.6% of Micware’s ordinary shares. The Japanese automotive software firm raised $22.8 million in its Nasdaq debut last week.
Dow edges up while Nasdaq falls as bond worries drag on

Futures Edge Higher Ahead of Nvidia Earnings as Wall Street Watches Key Report

20 May 2026
Nasdaq 100 futures rose 0.73% and S&P 500 futures gained 0.35% ahead of Wednesday’s open, with Nvidia set to report earnings after the close. Options markets priced in a 6.5% swing for Nvidia, equal to about $355 billion in market value. In premarket trading, Nvidia shares rose 1.84%, while Micron, Intel, and AMD also advanced. Fed minutes are due at 2:00 p.m. EDT.
Opendoor Technologies stock slips today as mortgage applications surge and Treasuries stay stubborn
Previous Story

Opendoor Technologies stock slips today as mortgage applications surge and Treasuries stay stubborn

Philip Morris stock edges up after PMI flags $20B+ U.S. investment push, FDA ZYN review ahead
Next Story

Philip Morris stock edges up after PMI flags $20B+ U.S. investment push, FDA ZYN review ahead

Go toTop